Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle?

Author： Delvigne A.   Carlier C.   Rozenberg S.  

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.76, Iss.4, 2001-10, pp. : 844-846

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist

By Williams S.C.   Gibbons W.E.   Muasher S.J.   Oehninger S.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1068-1072

Elsevier

Access to resources Recommend Favorite

Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles

By Jurema M.W.   Bracero N.J.   Garcia J.E.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1156-1161

Elsevier

Access to resources Recommend Favorite

Ovarian stimulation in in vitro fertilization with or without the ''long'' gonadotropin-releasing hormone agonist protocol: effect on cycle duration and outcome

By Beloosesky R.   Kol S.   Lightman A.   Itskovitz-Eldor J.  

Fertility and Sterility, Vol. 74, Iss. 1, 2000-07 ,pp. : 166-168

Elsevier

Access to resources Recommend Favorite

Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome

By Bosch E.   Valencia I.   Escudero E.   Crespo J.   Simon C.   Remohi J.   Pellicer A.  

Fertility and Sterility, Vol. 80, Iss. 6, 2003-12 ,pp. : 1444-1449

Elsevier

Access to resources Recommend Favorite

Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon)

By de Jong D.   Macklon N.S.   Eijkemans M.J.C.   Mannaerts B.M.J.L.   Coelingh Bennink H.J.T.   Fauser B.C.J.M.   for the Ganirelix Dose-Finding Study Group  

Fertility and Sterility, Vol. 75, Iss. 4, 2001-04 ,pp. : 688-693

Elsevier

Access to resources Recommend Favorite